• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TMS; TRANSCRANIAL MAGNETIC STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TMS; TRANSCRANIAL MAGNETIC STIMULATOR Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Headache (1880); Memory Loss/Impairment (1958); Tinnitus (2103); Twitching (2172); Dizziness (2194); Dysphasia (2195); Sneezing (2251); Anxiety (2328); Sleep Dysfunction (2517); Cognitive Changes (2551); Eye Pain (4467); Unspecified Eye / Vision Problem (4471)
Event Date 10/10/2021
Event Type  Injury  
Event Description
After tms treatment i suffered a short memory loss, eye pain, headaches, light sensitivity, felt like there was a bright light bulb in my eye which affected my vision, concentration problems ( still ongoing), speech problems eye twitching (ongoing) nonstop anxiety i have no good days anymore, everyday i'm miserable.Insomnia, lightheaded, tinnitus, trouble gathering my thoughts, having allergy like symptoms since like runny and stuffy nose, sneezing (ongoing).Neurostim.Fda safety report id # (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TMS
Type of Device
TRANSCRANIAL MAGNETIC STIMULATOR
MDR Report Key14789193
MDR Text Key294935584
Report NumberMW5110475
Device Sequence Number1
Product Code OBP
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 06/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Initial Date Manufacturer Received Not provided
Initial Date FDA Received06/22/2022
Patient Sequence Number1
Treatment
B COMPLEX; LORAZEPAM; METOPROLOL; NEXIUM
Patient Outcome(s) Other;
Patient Age54 YR
Patient SexFemale
Patient Weight86 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-